Premium
Progression of a focal ischemic lesion in rat brain during treatment with a novel glycine/nmda antagonist: An in vivo three‐dimensional diffusion‐weighted MR microscopy study
Author(s) -
Qiu Hui,
Hedlund Laurence W.,
Gewalt Sally L.,
Benveniste Helene,
Bare Thomas M.,
Johnson G. Allan
Publication year - 1997
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.1880070421
Subject(s) - stroke (engine) , medicine , in vivo , nmda receptor , antagonist , anesthesia , middle cerebral artery , occlusion , ischemia , cardiology , biology , mechanical engineering , receptor , microbiology and biotechnology , engineering
Stroke was induced in two groups of anesthetized rats by occlusion of the middle cerebral artery (MCA) and ipsilateral common carotid artery. Group 1 (control) received vehicle and group 2 received the glycine N‐methyl‐D‐aspartate (NMDA) antagonist ZD9379. Stroke volume was assessed by three‐dimensional diffusion‐weighted MR microscopy at 2.5 and 6 hours of MCA occlusion. At 2.5 hours, stroke volumes were identical in the two groups. At 6 hours, stroke volumes had increased by 15% in the control group; in contrast, the treated group showed a 40% reduced stroke volume. Conclusions from this in vivo study were as follows: ( a ) our technique allows more efficient and accurate measurement of stroke volume with an improvement in resolution over a previous method; ( b ) the ability to measure stroke volume at multiple time points shows volume change and assessment of time dependency of drug treatment; (c) at 6 hours, the glycine antagonist ZD9379 reduced stroke volume by 40%.